1. Home
  2. ALOT vs CUE Comparison

ALOT vs CUE Comparison

Compare ALOT & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AstroNova Inc.

ALOT

AstroNova Inc.

N/A

Current Price

$15.38

Market Cap

109.5M

Sector

Technology

ML Signal

N/A

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

N/A

Current Price

$27.82

Market Cap

88.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALOT
CUE
Founded
1969
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
109.5M
88.6M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
ALOT
CUE
Price
$15.38
$27.82
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$120.00
AVG Volume (30 Days)
45.4K
156.3K
Earning Date
04-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
83.94
61.11
EPS
N/A
N/A
Revenue
$150,515,000.00
$27,466,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
195.75
52 Week Low
$6.96
$0.17
52 Week High
$16.07
$41.42

Technical Indicators

Market Signals
Indicator
ALOT
CUE
Relative Strength Index (RSI) 67.92 65.60
Support Level $13.44 $0.30
Resistance Level N/A $41.42
Average True Range (ATR) 0.60 2.82
MACD -0.02 -0.13
Stochastic Oscillator 72.76 100.00

Price Performance

Historical Comparison
ALOT
CUE

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Aerospace. It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: